Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
Bosi C, Bartha Á, Galbardi B, Notini G, Naldini MM, Licata L, Viale G, Mariani M, Pistilli B, Ali HR, André F, Piras M, Callari M, Barreca M, Locatelli A, Viganò L, Criscitiello C, Pusztai L, Curigliano G, Győrffy B, Dugo M, Bianchini G. Bosi C, et al. Among authors: barreca m. Eur J Cancer. 2023 Dec;195:113379. doi: 10.1016/j.ejca.2023.113379. Epub 2023 Oct 11. Eur J Cancer. 2023. PMID: 37913680 Free article.
Development and validation of a gene expression-based Breast Cancer Purity Score.
Barreca M, Dugo M, Galbardi B, Győrffy B; NA-PHER2 consortium; NeoTRIP consortium; Valagussa P, Besozzi D, Viale G, Bianchini G, Gianni L, Callari M. Barreca M, et al. NPJ Precis Oncol. 2024 Oct 24;8(1):242. doi: 10.1038/s41698-024-00730-7. NPJ Precis Oncol. 2024. PMID: 39448787 Free PMC article.
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery.
Felicetti T, Di Iacovo N, Della Fazia MA, Piobbico D, Pieroni S, Pacetti M, Yu J, Sun Y, Massari S, Barreca ML, Sabatini S, Tabarrini O, Cecchetti V, Wang F, Pommier Y, Morlando M, Servillo G, Manfroni G. Felicetti T, et al. Among authors: barreca ml. RSC Med Chem. 2024 Sep 27. doi: 10.1039/d4md00649f. Online ahead of print. RSC Med Chem. 2024. PMID: 39399313 Free PMC article.
Citrus wastewater as a source of value-added products: Quali-quantitative analysis and in vitro screening on breast cancer cell lines.
Raimondi MV, Rigogliuso S, Saiano F, Poma P, Labbozzetta M, Barreca M, Barbera M, Bivacqua R, Li Petri G, Buscemi S, Sardo I, Spanò V, Palumbo Piccionello A, Montalbano A, Barraja P, Notarbartolo M. Raimondi MV, et al. Among authors: barreca m. Arch Pharm (Weinheim). 2024 Dec;357(12):e2400530. doi: 10.1002/ardp.202400530. Epub 2024 Oct 4. Arch Pharm (Weinheim). 2024. PMID: 39363788 Free PMC article.
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis.
Scalia F, Culletta G, Barreca M, Caruso Bavisotto C, Bivacqua R, D'Amico G, Alberti G, Spanò V, Tutone M, Almerico AM, Cappello F, Montalbano A, Barraja P. Scalia F, et al. Among authors: barreca m. Eur J Med Chem. 2024 Nov 15;278:116809. doi: 10.1016/j.ejmech.2024.116809. Epub 2024 Aug 28. Eur J Med Chem. 2024. PMID: 39226706 Review.
Discovery of 2-phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate.
Cernicchi G, Rampacci E, Massari S, Manfroni G, Barreca ML, Tabarrini O, Cecchetti V, Felicetti T, Di Luca M, Poma NV, Tavanti A, Passamonti F, Rindi L, Sabatini S. Cernicchi G, et al. Among authors: barreca ml. Arch Pharm (Weinheim). 2024 Oct;357(10):e2400296. doi: 10.1002/ardp.202400296. Epub 2024 Jun 26. Arch Pharm (Weinheim). 2024. PMID: 38923553
182 results